These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27178165)

  • 1. In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device.
    Lance KD; Bernards DA; Ciaccio NA; Good SD; Mendes TS; Kudisch M; Chan E; Ishikiriyama M; Bhisitkul RB; Desai TA
    Drug Deliv Transl Res; 2016 Dec; 6(6):771-780. PubMed ID: 27178165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
    Nagai N; Nezhad ZK; Daigaku R; Saijo S; Song Y; Terata K; Hoshi A; Nishizawa M; Nakazawa T; Kaji H; Abe T
    Int J Pharm; 2019 Aug; 567():118458. PubMed ID: 31247277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step solid-oil-water emulsion for sustained bioactive ranibizumab release.
    Chua HY; Lui YS; Bhuthalingam R; Agrawal R; Wong T; Preiser PR; Venkatraman S
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1143-1156. PubMed ID: 30354700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Correa ZM
    Exp Eye Res; 2016 Jul; 148():30-32. PubMed ID: 27181224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured thin film polymer devices for constant-rate protein delivery.
    Bernards DA; Lance KD; Ciaccio NA; Desai TA
    Nano Lett; 2012 Oct; 12(10):5355-61. PubMed ID: 22985294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.
    Fialho SL; Behar-Cohen F; Silva-Cunha A
    Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
    Zhang L; Si T; Fischer AJ; Letson A; Yuan S; Roberts CJ; Xu RX
    PLoS One; 2015; 10(8):e0135608. PubMed ID: 26273831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform.
    Tanetsugu Y; Tagami T; Terukina T; Ogawa T; Ohta M; Ozeki T
    Biol Pharm Bull; 2017; 40(2):145-150. PubMed ID: 28154252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery.
    Peyman GA; Yang D; Khoobehi B; Rahimy MH; Chin SY
    Ophthalmic Surg Lasers; 1996 May; 27(5):384-91. PubMed ID: 8860606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro characterization of ranibizumab release from the Port Delivery System.
    Yohe S; Maass KF; Horvath J; Rea J; Barteselli G; Ranade SV
    J Control Release; 2022 May; 345():101-107. PubMed ID: 35248647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations.
    Rahimy MH; Peyman GA; Chin SY; Golshani R; Aras C; Borhani H; Thompson H
    J Drug Target; 1994; 2(4):289-98. PubMed ID: 7858954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics.
    Lovett ML; Wang X; Yucel T; York L; Keirstead M; Haggerty L; Kaplan DL
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):271-8. PubMed ID: 25592326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.